Three-year follow-up of bintrafusp alfa, a bifunctional fusion protein targeting TGF-beta and PDL1, as second-line (2L) treatment of advanced non-small cell lung cancer (NSCLC)
Paz-Ares, L., Kim, T. M., Vicente, D., Felip, E., Lee, D. H., Lee, K. H., et al. (2021). Three-year follow-up … Read More
